| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |